Device Week, 29 April 2020 – Edwards Manages Dramatic Drop In TAVR Caused By Pandemic
Executive Summary
In this edition of the Device Week podcast, Medtech Insight’s Marion Webb and Reed Miller discuss how Edwards Lifesciences is handling the postponement of most transcatheter aortic valve replacement procedures during the pandemic and how it is planning to help customers complete these procedures by the end of 2020.
Listen to the podcast via the player below:
Medtech Insight articles addressed in this episode: